Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in NVS — Novartis AG

CIK 1595888 NEW YORK, NY
Back to NVS Full portfolio

Position in NVS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$55,977,834
+$55,977,834 QoQ
Shares Held
366,467
Ownership
0.019%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Mar 31, 2026
CallValue
$9,669,075
CallShares
63,300
PutValue
$21,171,150
PutShares
138,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $859,838,957 across 13 Drug Manufacturers - General names. NVS ranks #6 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AZN
Astrazeneca PLC
 844,701 $166,591,930
2 BMY
Bristol Myers Squibb Co
 2,265,508 $137,403,059
3 LLY
ELI LILLY & Co
 115,863 $106,567,309
4 GILD
Gilead Sciences, Inc.
 666,637 $92,909,198
5 NVO
Novo Nordisk A S
 2,024,007 $74,382,257
6 NVS
Novartis AG
This page 		366,467 $55,977,834
7 PFE
Pfizer Inc
 1,883,213 $52,880,620
8 MRK
Merck & Co., Inc.
 351,131 $42,237,546

All Filings in NVS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $55,977,834 366,467
2026-03-31 $9,669,075 63,300
2026-03-31 $21,171,150 138,600
2025-12-31 $4,701,367 34,100
2025-12-31 $22,321,153 161,900
2025-09-30 $2,398,088 18,700
2025-09-30 $2,487,856 19,400
2025-09-30 $13,632,167 106,302
2025-06-30 $5,816,344 48,065
2025-06-30 $1,706,241 14,100
2025-06-30 $3,944,926 32,600
2025-03-31 $11,310,537 101,458
2025-03-31 $30,701,592 275,400
2025-03-31 $813,804 7,300
2024-12-31 $1,012,024 10,400
2024-12-31 $1,099,603 11,300
2024-12-31 $13,939,169 143,245
2024-09-30 $6,780,888 58,954
2024-09-30 $207,036 1,800
2024-06-30 $11,097,070 104,237
2024-03-31 $3,293,849 34,052
2023-12-31 $17,743,962 175,735
2023-09-30 $18,006,810 176,780
2023-06-30 $12,029,783 119,213
2023-03-31 $23,144,072 251,566
2022-12-31 $42,328,772 466,587
2022-09-30 $22,508,156 296,121
2022-06-30 $30,303,497 358,494
2022-03-31 $1,404,000 16,000
2022-03-31 $52,007,231 592,675
2022-03-31 $16,418,025 187,100
2021-12-31 $3,542,535 40,500
2021-12-31 $14,957,370 171,000
2021-12-31 $28,754,012 328,730
2021-09-30 $12,259,230 149,905
2021-09-30 $21,328,224 260,800
2021-09-30 $4,694,172 57,400
2021-06-30 $16,612,978 182,080
2021-06-30 $4,671,488 51,200
2021-06-30 $16,076,488 176,200
2021-03-31 $23,293,300 272,500
2021-03-31 $859,073 10,050
2021-03-31 $7,205,964 84,300
2020-12-31 $29,358,287 310,900
2020-12-31 $12,381,188 131,115
2020-12-31 $10,236,212 108,400
2020-09-30 $7,443,776 85,600
2020-09-30 $19,287,728 221,800
2020-09-30 $16,962,678 195,063
2020-06-30 $6,052,662 69,300

Report a Problem

Category
Description
Email (optional, for follow-up)